A/Prof Terence Chua

BScMed (Hons)

MBBS

MRCS (Ed)

PhD

FRACS

Article: Warning Signs for Bowel Cancer: https://www.healthsharedigital.com/health-insights/dont-wait-until-the-warning-signs-to-test-for-bowel-cancer/

1. Chua TC, Yan TD, Saxena A, Morris DL. (2009). Should the Treatment of Peritoneal Carcinomatosis by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Still Be Regarded as a Highly Morbid Procedure? A Systematic Review of Morbidity and Mortality. Annals of Surgery. 249(6): 900-7.
2. Chua TC, Yan TD, Smigielski ME, Zhu KJ, Ng KM, Zhao J, Morris DL. (2009). Long term survival in patients with pseudomyxoma peritonei treated with cytoreductive surgery and perioperative intraperitoneal chemotherapy: over 10 years experience from a single institution. Annals of Surgical Oncology. 16(7): 1903-11.
3. Chua TC, Liauw W, Morris DL. (2009). The St George Hospital Peritoneal Surface Malignancy Program – Where are we now? ANZ Journal of Surgery. 79(6): 416-8.
4. Chua TC, Liauw W, Morris DL. (2009). New treatments in peritoneal carcinomatosis. Medical Journal of Australia. 191(1): 3-4.
5. Chua TC. (2009). Gastrointestinal oncological surgery in patients with metastatic cancer treated with angiogenesis inhibitors: safe or not? ANZ Journal of Surgery. 79(10): 672-3.
6. Yan TD, Deraco M, Baratti D, Kusamura S, Elias D, Glehen O, Gilly FN, Levine EA, Shen P, Mohamed F, Moran BJ, Morris DL, Chua TC, Piso P, Sugarbaker PH. (2009). Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Malignant Peritoneal Mesothelioma: Multi-Institutional Experience. Journal of Clinical Oncology. 27(36): 6237-42.
7. Chua TC, Saxena A, Schelleken A, Liauw W, Yan TD, Fransi S, Zhao J, Morris DL. (2010). Mortality and morbidity outcomes of cytoreductive surgery and perioperative intraperitoneal chemotherapy at a single tertiary institution: towards a new perspective of this treatment. Annals of Surgery. 251(1): 101-6.
8. Chua TC, Martin S, Saxena A, Liauw W, Yan TD, Zhao J, Lok I, Morris DL. (2010). Evaluation of the Cost-Effectiveness of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (Peritonectomy) at the St George Hospital Peritoneal Surface Malignancy Program. Annals of Surgery. 251(2): 323-9.
9. Saxena A, Bester L, Chua TC, Chu FC, Morris DL. (2010). Yttrium-90 Radiotherapy for Unresectable Intrahepatic Cholangiocarcinoma: A Preliminary Assessment of this Novel Treatment Option. Annals of Surgical Oncology. 17: 484-491.
10. Chua TC, Saxena A, Liauw W, Kokandi A, Morris DL. (2010). Systematic Review of Randomized and Nonrandomized Trials of the Clinical Response and Outcomes of Neoadjuvant Systemic Chemotherapy for Resectable Colorectal Liver Metastases. Annals of Surgical Oncology. 17: 492-501.
11. Chua TC, Saxena A, Chu F, Liauw W, Zhao J, Morris DL. (2010). Clinicopathological Determinants of Survival after Hepatic Resection of Hepatocellular Carcinoma in 97 Patients – Experience From an Australian Hepatobiliary Unit. Journal of Gastrointestinal Surgery. 14(9): 1370-80.
12. Chua TC, Yan TD, Deraco M, Baratti D, Kusamura S, Elias D, Glehen O, Gilly FN, Levine EA, Shen P, Mohamed F, Moran BJ, Morris DL, Glockzin G, Piso P, Sugarbaker PH. (2011). Multi-Institutional Experience of Diffuse Intra-Abdominal Multicystic Peritoneal Mesothelioma. British Journal of Surgery. 98(1):60-4.
13. Esquivel J, Averbach A, Chua TC. (2011).Laparoscopic Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Patients with Limited Peritoneal Surface Malignancies: Feasibility, Morbidity and Outcomes in an Early Experience. Annals of Surgery. 253(4):764-8.
14. Chua TC, Liauw W, Zhao J, Morris DL. (2011). Upfront compared to delayed cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei is associated with considerably lower perioperative morbidity and recurrence rate. Annals of Surgery. 253(4):769-773.
15. Yan TD, Deraco M, Elias D, Glehen O, Levine EA, Moran BJ, Morris DL, Chua TC, Piso P, Sugarbaker PH and Peritoneal Surface Oncology Group. (2011). A Novel Tumor Node Metastasis (TNM) Staging System of Diffuse Malignant Peritoneal Mesothelioma Based on Outcome Analysis of a Multi-institutional Database. Cancer. 117(9): 1855-63.
16. Chua TC, Liauw W, Chu F, Morris DL. (2012). Viewing Metastatic Colorectal Cancer as a Curable Chronic Disease. American Journal of Clinical Oncology. 35(1): 77-80.
17. Bester L, Meteling B, Pocock N, Pavlakis N, Chua TC, Saxena A, Morris DL. (2012). Radioembolization versus Standard Care of Hepatic Metastases: Comparative Retrospective Cohort Study of Survival Outcomes and Adverse Events in Salvage Patients. Journal of Vascular Interventional Radiology. 23(1): 96-105.
18. Klaver YL, Chua TC, de Hingh IH, Morris DL. (2012). Outcomes of Elderly Patients Undergoing Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy for Colorectal Cancer Peritoneal Carcinomatosis. Journal of Surgical Oncology. 105(2): 113-8.
19. Saxena A,Chua TC, Chu F, Morris DL. (2012). Hepatic Resection for Transplantable Hepatocellular Carcinoma for Patients Within Milan and UCSF Criteria. American Journal of Clinical Oncology. 35(2): 141-5.
20. Ng KM, Chua TC, Saxena A, Zhao J, Chu F, Morris DL. (2012). Two Decades of Experience with Hepatic Cryotherapy for Advanced Colorectal Metastases. Annals of Surgical Oncology. 19(4): 1276-83.
21. Chua TC, Liauw W, Morris DL. (2012). Early Recurrence of Pseudomyxoma Peritonei Following Treatment Failure of Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy is Indicative of a Poor Survival Outcome. International Journal of Colorectal Disease. 27(3): 381-9.
22. Chua TC, Morris DL. (2012). Therapeutic Potential of Surgery for Metastatic Colorectal Cancer. Scandinavian Journal of Gastroenterology.47(3): 258-68.
23. Chua TC, Pelz JO, Morris DL. (2012). Surgery for Colorectal Peritoneal Carcinomatosis. Scandinavian Journal of Gastroenterology. 47(3): 277-285.
24. Chua TC, Merrett ND. (2012). Clinicopathologic Factors Associated with HER2-Positive Gastric Cancer and its Impact on Survival Outcomes - A Systematic Review. International Journal of Cancer. 130(12): 2845-56.
25. Chua TC, Morris DL. (2012). Exploring the Role of Resection of Extrahepatic Metastases from Hepatocellular Carcinoma. Surgical Oncology. 21(2): 95-101.
26. Chua TC, Chong CH, Liauw W, Zhao J, Morris DL. (2012). Inflammatory Markers in Blood and Serum Tumor Markers Predicts Survival in Patients with Epithelial Appendiceal Neoplasms Undergoing Surgical Cytoreduction and Intraperitoneal Chemotherapy. Annals of Surgery. 256(2): 342-9.
27. Chua TC, Moran BJ, Sugarbaker PH, Levine EA, Glehen O, Gilly FN, Baratti D, Deraco M, Elias D, Sardi A, Liauw W, Yan TD, Barrios P, Portilla AG,de Hingh IH, Ceelen WP, Pelz JO, Piso P, González-Moreno S, Van Der Speeten K, Morris DL. (2012). Early and Long-term Outcome Data on 2298 Patients with Pseudomyxoma Peritonei of Appendiceal Origin Treated by a Strategy of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.Journal of Clinical Oncology. 30(20): 2449-56.
28. Chua TC, Morris DL. (2012). Resectable Colorectal Liver Metastases: Optimal Sequencing of Chemotherapy. Journal of Gastrointestinal Cancer. 43(3): 496-498.
29. Chua TC, Morris DL. (2012). Colorectal Liver Metastases in the Presence of Extrahepatic Disease – A New Criteria for Oncologic Resection. Journal of Gastrointestinal Cancer. 43(3): 502-504.
30. Kerscher AG, Chua TC, Gasser M, Maeder U, Kunzmann V, Isbert C, Germer CT, Pelz JO. (2013). Impact of Peritoneal Carcinomatosis in the Disease History of Colorectal Cancer Management: A Longitudinal Experience of 2406 Patients over Two Decades. British Journal of Cancer. 108(7): 1432-9.
31. Yang TX, Billah B, Morris DL, Chua TC. (2013). Palliative Resection of the Primary Tumor in Patients with Stage IV Colorectal Cancer: Systematic Review and Meta-analysis of Early Outcomes after Laparoscopic versus Open Colectomy. Colorectal Disease. 15(8)e407-19.
32. Chua TC, Gill AJ, Samra JS. (2015). An unusual cause of torrential lower gastrointestinal hemorrhage. Gastroenterology. 148(5):e10-11.
33. Chua TC, Wang F, Maher R, Ganadha S, Mittal A, Samra JS. (2015). Endovascualr stenting of mesenterico-portal vein stenosis to reduce blood flow through venous collaterals prior to pancreatoduodenectomy. Langenbecks Arch Surg. 400(5):629-31.
34. Chua TC, Yang TX, Gill AJ, Samra JS. (2016). Systematic review and meta-analysis of enucleation versus standardized resection for small pancreatic lesions. Annals of Surgical Oncology. 23(2):592-9.
35. Huang Y, Chua TC, Maddern GJ, Samra JS. (2017). Robotic cholecystectomy versus conventional laparoscopic cholecystectomy: A meta-analysis. Surgery. 161(3): 628-636.
36. Chua TC, Mittal A, Nahm C, Hugh TJ, Arena J, Gill AJ, Samra JS. (2018). Pancreatoduodenectomy in a public versus private teaching hospital in comparable with some minor variations. ANZ Journal of Surgery. 88(6): E526-531.
37. Chua TC, Jeyakumar A, Ip JC, Yuide PJ, Burstow MB. (2020). Conservative management of acute perforated diverticulitis: A systematic review. J Dig Dis. 21(2): 63-68.